Balancing statistical and ethical considerations in planning clinical trials: recommendations for response-adaptive randomization urn designs

被引:2
|
作者
Piccorelli, Annalisa V. [1 ]
Fraker, Sarah A. [2 ]
机构
[1] Univ Wyoming, Dept Math & Stat, Dept 3036,1000 E Univ Ave, Laramie, WY 82071 USA
[2] HCA Holdings Inc, Clin Serv Grp, Nashville, TN USA
关键词
Birth-and-Death Urn with Immigration; equal allocation; Modified Play-the-Winner; randomized-play-the-winner; response-adaptive randomization; PLAY-WINNER RULE;
D O I
10.1080/10543406.2018.1437172
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During a clinical trial, balancing statistical and ethical considerations are important. Response-adaptive randomization methods use the information from past patients to increase the probability of the next patient receiving the better treatment while avoiding the statistical concern of selection bias. We compared three response-adaptive randomization urn designs, Randomized Play-the-Winner, Modified Play-the-Winner, and Birth-and-Death Urn with Immigration, to the traditional equal allocation design with respect to power and allocation of patients to the better treatment. Because these designs have been described separately, our motivation was to systematically compare them and provide recommendations. With simulations, we varied sample size and combinations of treatment and control success probabilities. We also compared the response-adaptive randomization designs using exact distribution algorithms and applied them to past clinical trial data that used an equal allocation design. We conclude that Modified Play-the-Winner tends to be unpredictable and can result in allocation of all of the patients to the better treatment. Randomized Play-the-Winner allocates more patients to the better treatment than Birth-and-Death Urn with Immigration, but Birth-and-Death Urn with Immigration is more consistent in its allocations. Randomized Play-the-Winner and Birth-and-Death Urn with Immigration produce allocations that have comparable powers to equal allocation design.
引用
收藏
页码:1105 / 1118
页数:14
相关论文
共 50 条
  • [1] Higher order response-adaptive urn designs for clinical trials with highly successful treatments
    Ivanova, Anastasia
    Hoberman, Steven
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2015, 64 (01) : 175 - 189
  • [2] Rejoinder: Response-Adaptive Randomization in Clinical Trials
    Robertson, David S.
    Lee, Kim May
    Lopez-Kolkovska, Boryana C.
    Villar, Sofia S.
    [J]. STATISTICAL SCIENCE, 2023, 38 (02) : 233 - 239
  • [3] Comment: Response-Adaptive Randomization in Clinical Trials: From Myths to Practical Considerations
    Duan, Yunshan
    Mueller, Peter
    Ji, Yuan
    [J]. STATISTICAL SCIENCE, 2023, 38 (02) : 212 - 215
  • [4] Response-adaptive randomization for clinical trials with continuous outcomes
    Zhang, Lanju
    Rosenberger, William F.
    [J]. BIOMETRICS, 2006, 62 (02) : 562 - 569
  • [5] Response-Adaptive Randomization in Clinical Trials: From Myths to Practical Considerations1
    Robertson, David S.
    Lee, Kim May
    Lopez-Kolkovska, Boryana C.
    Villar, Sofia S.
    [J]. STATISTICAL SCIENCE, 2023, 38 (02) : 185 - 208
  • [6] THE USE OF RESPONSE-ADAPTIVE DESIGNS IN CLINICAL-TRIALS
    ROSENBERGER, WF
    LACHIN, JM
    [J]. CONTROLLED CLINICAL TRIALS, 1993, 14 (06): : 471 - 484
  • [7] EFFICIENT AND ETHICAL RESPONSE-ADAPTIVE RANDOMIZATION DESIGNS FOR MULTI-ARM CLINICAL TRIALS WITH WEIBULL TIME-TO-EVENT OUTCOMES
    Sverdlov, Oleksandr
    Ryeznik, Yevgen
    Wong, Weng-Kee
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (04) : 732 - 754
  • [8] A Markov decision process for response-adaptive randomization in clinical trials
    Merrell, David
    Chandereng, Thevaa
    Park, Yeonhee
    [J]. COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2023, 178
  • [9] Response-adaptive randomization for clinical trials with adjustment for covariate imbalance
    Ning, Jing
    Huang, Xuelin
    [J]. STATISTICS IN MEDICINE, 2010, 29 (17) : 1761 - 1768
  • [10] Block response-adaptive randomization in clinical trials with binary endpoints
    Magirr, Dominic
    [J]. PHARMACEUTICAL STATISTICS, 2011, 10 (04) : 341 - 346